Observations on a proposed measure of genotoxicity in rat gastric mucosa

S Holt1, Z H Zhu, R E Powers

  • 1Department of Internal Medicine, University of South Carolina School of Medicine, Columbia.

Gastroenterology
|September 1, 1991
PubMed

Insights

A novel assay for gastric mucosal genotoxicity was evaluated using omeprazole. The assay proved unreliable for detecting unscheduled DNA synthesis, questioning previous findings on omeprazole

Area of Science:

  • Toxicology
  • Genetics
  • Gastroenterology

Background:

  • Current methods for assessing drug effects on gastric mucosa have limitations.
  • A novel genotoxicity assay using [3H]thymidine incorporation was proposed.
  • Omeprazole's potential for direct DNA damage raised safety concerns.

Purpose of the Study:

  • To evaluate the applicability of the proposed genotoxicity assay.
  • To investigate the effects of omeprazole on gastric mucosal DNA.
  • To validate the assay's reliability for detecting unscheduled DNA synthesis.

Main Methods:

  • Rats were administered omeprazole, control agents, and carcinogens (MNNG).
  • [3H]thymidine labeling was used to measure DNA incorporation in gastric mucosal cells.
  • Hydroxyurea pretreatment and flow cytometry analyzed DNA synthesis and cell cycle.

Main Results:

  • Omeprazole did not increase [3H]thymidine incorporation across various doses.
  • The carcinogen MNNG significantly increased [3H]thymidine incorporation.
  • The assay primarily measured replicative, not unscheduled, DNA synthesis due to cell contamination.

Conclusions:

  • The proposed genotoxicity assay is unreliable for measuring unscheduled DNA synthesis in its current form.
  • Conclusions regarding omeprazole's genotoxic effects based on this assay are questionable.
  • Further refinement of the assay is needed for accurate genotoxicity assessment.